Raphaelle Jaquet-Pilloud
Quick facts
Phase 3 pipeline
- NaCl 3% · Neurology / Critical Care
Hypertonic saline (3% NaCl) increases serum osmolality to draw fluid from intracellular and interstitial spaces into the intravascular compartment, reducing cerebral edema and intracranial pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Raphaelle Jaquet-Pilloud
What is Raphaelle Jaquet-Pilloud's pipeline?
Raphaelle Jaquet-Pilloud has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include NaCl 3%.
Related
- Sector hub: All tracked pharma companies